Syed Omar Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Syed Omar Ahmad has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Beth Levant
University of Kansas Medical Center
3 shared publications - Dana Stiles
Office of Institutional Research, Saint Louis University, St. Louis, MO 63103, USA
3 shared publications - Michelle Healy-Stoffel
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA
3 shared publications - Jason K. Longhurst
Department of Physical Therapy and Athletic Training, Saint Louis University, Saint Louis, MO, USA
2 shared publications - John A. Stanford
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA
2 shared publications B. Tipton
NeuroScience Associates, Knoxville, 37934, TN, USA
1 shared publication
Latest Publications
- Open Access
Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease
Background: Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting millions of people worldwide. PD results in motor and cognitive dysfunction. While there is no proven cure for PD, it is widely agreed that aerobic exercises and occupations can help slow the progression of the disease and keep some motor-related symptoms from developing. The most effective forms of exercise to slow the progression of motor symptoms in Parkinson’s disease have also been studied. Research Question: This research article aims to compare the differences in outcomes of exercise on cognitive outcomes in Parkinson’s Disease, as evaluated by meta-analysis. Methods: Key terms were Parkinson’s Disease and exercise terms. These search terms were then entered to electronic databases—Ovid MEDLINE, SCOPUS, and CINAHL—from March 2018 to May 2023. An ancestral bibliography was also performed. Results: Two reviewers screened the title and abstract records (n = 528) found in the initial search. Our review identified 18 studies which met inclusion criteria for meta-analysis. The meta-analysis found an effect of exercise on cognition of patients with PD (d = −0.03) which was not significant (CI95% of −0.13 < µ < 0.08; p > 0.05, as the CI includes zero). Additionally, the homogeneity analysis was not significant (Q (17) = 2.83; p > 0.05).
Open AccessMeta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease
Background: Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting millions of people worldwide. PD results in motor and cognitive dysfunction. While there is no proven cure for PD, it is widely agreed that aerobic exercises and occupations can help slow the progression of the disease and keep some motor-related symptoms from developing. The most effective forms of exercise to slow the progression of motor symptoms in Parkinson’s disease have also been studied. Research Question: This research article aims to compare the differences in outcomes of exercise on cognitive outcomes in Parkinson’s Disease, as evaluated by meta-analysis. Methods: Key terms were Parkinson’s Disease and exercise terms. These search terms were then entered to electronic databases—Ovid MEDLINE, SCOPUS, and CINAHL—from March 2018 to May 2023. An ancestral bibliography was also performed. Results: Two reviewers screened the title and abstract records (n = 528) found in the initial search. Our review identified 18 studies which met inclusion criteria for meta-analysis. The meta-analysis found an effect of exercise on cognition of patients with PD (d = −0.03) which was not significant (CI95% of −0.13 < µ < 0.08; p > 0.05, as the CI includes zero). Additionally, the homogeneity analysis was not significant (Q (17) = 2.83; p > 0.05).
- Open Access
- 24 October 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (8) , 1594-1601
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease
Background: Best practice guidelines in Parkinson's disease (PD) calls for the immediate initiation of rehabilitation therapies (inclusive of physical (PT) and occupational therapy (OT)) to prevent or ameliorate the loss of function and quality of life associated with disease progression. Objective: The purpose of this study was to determine the utilization of PT and OT services within the first 2 years following PD diagnosis and to observe longitudinal trends in PT and OT utilization early following PD diagnosis. Methods: This retrospective cohort study accessed 12 years (2011 to 2023) of data from electronic health records at a midwestern US healthy system. Patients with new PD diagnoses and two-years of visit history were included. The primary outcome was utilization of PT or OT services within two-years of PD diagnosis. Data extracted included demographics and PD therapies. Records of 9720 patients were included in the analyses. Results: Overall, 36.9% of the cohort ( n = 3586) received either physical or occupational therapy within two years of receipt of PD diagnosis. Increasing age, higher comorbidity index, female gender, use of dopamine replacement therapies, and African American race were all positively associated with receipt of PT or OT services ( p s < 0.007). The longitudinal trend revealed an average year over year increase in PT/OT utilization of 1.4% between 2013 and 2021 ( p < 0.001). Conclusions: This study shows a promising increase in utilization of PT and OT services over previous reports and longitudinally, however it continues to convey how far clinical practice continues to lag behind best practice and scientific recommendation.
- 24 October 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (8) , 1594-1601
Open AccessIncreasing trends in utilization of physical and occupational therapy services in early Parkinson's disease
Background: Best practice guidelines in Parkinson's disease (PD) calls for the immediate initiation of rehabilitation therapies (inclusive of physical (PT) and occupational therapy (OT)) to prevent or ameliorate the loss of function and quality of life associated with disease progression. Objective: The purpose of this study was to determine the utilization of PT and OT services within the first 2 years following PD diagnosis and to observe longitudinal trends in PT and OT utilization early following PD diagnosis. Methods: This retrospective cohort study accessed 12 years (2011 to 2023) of data from electronic health records at a midwestern US healthy system. Patients with new PD diagnoses and two-years of visit history were included. The primary outcome was utilization of PT or OT services within two-years of PD diagnosis. Data extracted included demographics and PD therapies. Records of 9720 patients were included in the analyses. Results: Overall, 36.9% of the cohort ( n = 3586) received either physical or occupational therapy within two years of receipt of PD diagnosis. Increasing age, higher comorbidity index, female gender, use of dopamine replacement therapies, and African American race were all positively associated with receipt of PT or OT services ( p s < 0.007). The longitudinal trend revealed an average year over year increase in PT/OT utilization of 1.4% between 2013 and 2021 ( p < 0.001). Conclusions: This study shows a promising increase in utilization of PT and OT services over previous reports and longitudinally, however it continues to convey how far clinical practice continues to lag behind best practice and scientific recommendation.
- Open Access
- 17 August 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (16) , 7236
Commentary on A Meta-Analysis of Exercise Intervention and the Effect on Parkinson’s Disease Symptoms: What Activities Are Best?
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting millions of people worldwide
- 17 August 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (16) , 7236
Open AccessCommentary on A Meta-Analysis of Exercise Intervention and the Effect on Parkinson’s Disease Symptoms: What Activities Are Best?
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting millions of people worldwide
- 3 March 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 801, 137162
A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms
- 3 March 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 801, 137162
A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms
- Open Access
- 25 May 2022
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (6)
The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
Heterozygous mutations in the GBA1 gene – encoding lysosomal glucocerebrosidase (GCase) – are the most common genetic risk factors for Parkinson's disease (PD). Experimental evidence suggests a correlation between decreased GCase activity and accumulation of alpha-synuclein (aSyn). To enable a better understanding of the relationship between aSyn and GCase activity, we developed and characterized two mouse models that investigate aSyn pathology in the context of reduced GCase activity. The first model used constitutive overexpression of wild-type human aSyn in the context of the homozygous GCase activity-reducing D409V mutant form of GBA1. Although increased aSyn pathology and grip strength reductions were observed in this model, the nigrostriatal system remained largely intact. The second model involved injection of aSyn preformed fibrils (PFFs) into the striatum of the homozygous GBA1 D409V knock-in mouse model. The GBA1 D409V mutation did not exacerbate the pathology induced by aSyn PFF injection. This study sheds light on the relationship between aSyn and GCase in mouse models, highlighting the impact of model design on the ability to model a relationship between these proteins in PD-related pathology.
- 25 May 2022
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (6)
Open AccessThe GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
Heterozygous mutations in the GBA1 gene – encoding lysosomal glucocerebrosidase (GCase) – are the most common genetic risk factors for Parkinson's disease (PD). Experimental evidence suggests a correlation between decreased GCase activity and accumulation of alpha-synuclein (aSyn). To enable a better understanding of the relationship between aSyn and GCase activity, we developed and characterized two mouse models that investigate aSyn pathology in the context of reduced GCase activity. The first model used constitutive overexpression of wild-type human aSyn in the context of the homozygous GCase activity-reducing D409V mutant form of GBA1. Although increased aSyn pathology and grip strength reductions were observed in this model, the nigrostriatal system remained largely intact. The second model involved injection of aSyn preformed fibrils (PFFs) into the striatum of the homozygous GBA1 D409V knock-in mouse model. The GBA1 D409V mutation did not exacerbate the pathology induced by aSyn PFF injection. This study sheds light on the relationship between aSyn and GCase in mouse models, highlighting the impact of model design on the ability to model a relationship between these proteins in PD-related pathology.
- 1 July 2014
- Published by Elsevier in Brain Research
- Vol. 1574, 113-119
Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat
- 1 July 2014
- Published by Elsevier in Brain Research
- Vol. 1574, 113-119
Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat
- 1 June 2013
- Published by Elsevier in Neuroscience Letters
- Vol. 546, 26-30
Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats
- 1 June 2013
- Published by Elsevier in Neuroscience Letters
- Vol. 546, 26-30
Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats